Skip to main content

Advertisement

SpringerLink
Log in

Tumor cells do not arise frequently

  • Review
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

A hypothesis greatly influencing thinking and experimental work in tumor immunology is that many tumor cells arise daily in an organism. However, relatively low numbers of tumours become clinically manifest. This discrepancy has intially led to the hypothesis that the great majority of these potential tumors is killed by immune surveillance mechanisms. After some time, however, serious objections were raised against this function of the immune system. When the interest in immune surveillance faded away, investigators started to study natural resistance against the de novo arising tumor cells. In this paper the data on natural resistance (and immune surveillance) are reviewed. These data lead to the conclusion than an efficient natural resistance that could kill many de novo arising tumor cells is lacking. Taken together the data suggest that no tumors arise when immune surveillance and/or natural resistance are absent. This implies that tumor cells probably do not arise frequently. Acceptance of this conclusion leads to a reappraisal of the role of immune surveillance and natural resistance against tumor cells. This reappraisal will mean a shift from (a) the hypothesized failsafe mechanisms to (b) mechanisms that may or may not kill rarely arising tumor cells, depending for instance on the antigenicity of the tumor cells and their sensitivity to tumoricidal mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abo T, Miller CA, Gartland CL, Balch CM (1983) Differentiation stages of human natural killer cells in lymphoid tissue from fetal to adult life. J Exp Med 157:273

    Google Scholar 

  2. Baldwin RW (1981) Immunotherapy of cancer. Cancer Chemother Ann 3:178

    Google Scholar 

  3. Bauer KH (1928) Mutationstheorie der Geschwulst-Entstehung. Übergang von körperzellen in Geschwulstzellen durch Genänderung. Springer, Berlin

    Google Scholar 

  4. Becker S, Kiessling R, Lee N, Klein G (1978) Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. J Natl Cancer Inst 61:1495

    Google Scholar 

  5. Burdette WJ (1955) The significance of mutation in relation to the origin to tumor: A review. Cancer Res 15:201

    Google Scholar 

  6. Burnett FM (1971) Immunological surveillance in neoplasia. Transplant Rev 7:3

    Google Scholar 

  7. Chee DO, Townsend CM, Galbraith MA, Eiber FR, Morton DL (1978) Selective reduction of human tumor cell populations by human granulocytes in vitro. Cancer Res 38:4534

    Google Scholar 

  8. Dent PB, Fish LA, White JG, Good RA (1966) Chediak Higashi syndrome. Observations on the nature of the associated malignancy. Lab Invest 15:1634

    Google Scholar 

  9. Dvorak AM, Galli SJ, Galli AS, Hammond ME, Churchill WH, Dvorak HF (1979) Tumor-basophil interactions in vitro — A scanning and transmission electron microscopic study. J Immunol 122:2447

    Google Scholar 

  10. Farram E, Nelson DS (1980) Mouse mast cells as antitumor effector cells. Cell Immunol 55:294

    Google Scholar 

  11. Folkman J, (1976). The vascularization of tumors. Sci Am 234/5:58

    Google Scholar 

  12. Henderson WR, Chi EY, Jong EC, Klebanoff SJ (1981) Mast cell-mediated tumor cell cytotoxicity: Role of the peroxidase system. J Exp Med 153:520

    Google Scholar 

  13. Herberman RB (1980) Natural cell-mediated immunity against tumors. Academic, London

    Google Scholar 

  14. Hibbs JB (1974) Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J Natl Cancer Inst 53:1487

    Google Scholar 

  15. Kaplan AM, Morahan PS, Regelson W (1974) Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer. J Natl Cancer Inst 52:1919

    Google Scholar 

  16. Keller R (1974) Modulation of cell proliferation by macrophages: a possible function apart from cytotoxic tumor rejection. Br J Cancer 30:401

    Google Scholar 

  17. Klein G, Klein E (1977) Rejectability of virus-induced tumors and non-rejectability of spontaneous tumors: A lesson in contrasts. Transplant Proc 9:1095

    Google Scholar 

  18. Korec S, Herberman RB, Dean HJ, Cannon GB (1980) Cytostasis of tumor cell lines by human granulocytes. Cell Immunol 53:104

    Google Scholar 

  19. Louis CJ (1978) Tumors: Basic principles and clinical aspects. Churchill Livingstone, Edinburgh

    Google Scholar 

  20. Mantovani A, Tagliabue A, Dean J, Jerrels TR, Herberman RB (1979) Cytolytic activity of circulating human monocytes on transformed and untransformed human fibroblasts. Int J Cancer 23:28

    Google Scholar 

  21. Martin WJ, Martin SE (1974) Naturally occurring cytotoxic anti-tumor antibodies in sera of congenically athymic (nude) mice. Nature 249:564

    Google Scholar 

  22. Meltzer MS, Tucker RW, Breuer AC (1975) Interaction of BCG-activated macrophages with neoplastic cell lines in vitro: Cinemicrographic analysis. Cell Immunol 17:30

    Google Scholar 

  23. Minato M, Bloom BR, Jones C, Holland J, Reid LM (1979). Mechanism of rejection of virus persistently infected cells by athymic nude mice. J Exp Med 149:1117

    Google Scholar 

  24. Nehlsen SL (1971) Prolonged administration of antithymocyte serum in mice. I: Observations on cellular and humoral immunity. Clin Exp Immunol 9:63

    Google Scholar 

  25. Outzen HC, Custer RP, Eaton GJ, Prehn RT (1975) Spontaneous and induced tumor incidence in germ-free nude mice. J Reticuloendothel Soc 17:1

    Google Scholar 

  26. Pels E, Den Otter W (1979) Natural cytotoxic macrophages in the peritoneal cavity of mice. Br J Cancer 40:856

    Google Scholar 

  27. Penn I, Halgrimson CG, Starzl TE (1971) De novo malignant tumors in organ transplant recipients. Transplant Proc 3:773

    Google Scholar 

  28. Piessens WF, Churchill WH, David JR (1975) Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells. J Immunol 114:293

    Google Scholar 

  29. Prehn RT (1976) Do tumors grow because of the immune response of the host? Transplant Rev 28:34

    Google Scholar 

  30. Roder J, Duwe A (1979) The beige mutation in the mouse selectively imparts natural killer cell function. Nature 278:451

    Google Scholar 

  31. Roder JC, Haliotis T (1980) Do NK cells play a role in antitumor surveillance? Immunol Today 1:96

    Google Scholar 

  32. Roder JC, Kiessling R (1978) Target-effector interaction in the natural killer cell system. I: Covariance and genetic control of cytolytic and target cell binding subpopulations in the mouse. Scand J Immunol 8:135

    Google Scholar 

  33. Roder JC, Laing L, Haliotis T (1982) In: Herberman RB (ed) NK cells: fundamental aspects and role in cancer. North Holland, Amsterdam (Human cancer immunology, vol 6)

  34. Rygaard J, Povlsen CO (1976) The nude mouse vs hypothesis of immunological surveillance. Transplant Rev 28:43

    Google Scholar 

  35. Saksela RB, Timonen T (1980) Morphology and surface properties of human NK cells. In: Herbermann RB (ed) Natural cell-mediated immunity against tumors. Academic, London

    Google Scholar 

  36. Salmon JC, Cream-Goldberg N, Lynch NR (1980) Cancer induction by methylcholanthrene and metastatic spread of transplantable tumor in Chediak Higashi (beige mice). Cancer Immunol Immunother 8:67

    Google Scholar 

  37. Sanford BH, Kohn HI, Daly JJ, Soo SF (1973) Long-term spontaneous tumor incidence in neonatally thymectomized mice. J Immunol 110:1437

    Google Scholar 

  38. Stern C (1973) Principles of human genetics. Freeman, San Francisco

    Google Scholar 

  39. Stutman O (1974) Tumor development after 3-methylcholanthrene in immunologically deficient athymic-nude mice. Science 183:534

    CAS  PubMed  Google Scholar 

  40. Sullivan JL, Byron KS, Brewster FE, Purtilo DT (1980) Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 210:543

    Google Scholar 

  41. Talmadge JE, Meyers KM, Prieur DJ, Starkey JR (1980) Role of NK cells in tumor growth and metastasis in beige mice. Nature 284:622

    Google Scholar 

  42. Takasugi M, Akira D, Kinoshita K (1975) Ganulocytes as effectors in cell-mediated cytotoxicity of adherent target cells. Cancer Res 35:2169

    Google Scholar 

  43. Timonen T, Ortaldo JR, Herberman RB (1981) Characteristics of human larger granular lymphocytes and relationship to natural killer and K cells. J. Exp. Med. 153:569

    Google Scholar 

  44. Van Furth R (1980) Cells of the mononuclear phagocyte system. Nomenclature in terms of sites and conditions. In: Van Furth R (ed) Mononuclear phagocytes, part I. Nijhoff The Hague

    Google Scholar 

  45. Vánky F, Argov S, Einhorn S, Klein E (1980) Role of alloantigens in natural killing: allogeneic but not autologous tumor biopsy cells are sensitive for interferon induced cytotoxicity of human blood lymphocytes. J Exp Med 151:1151

    Google Scholar 

  46. Vose BM, Moore M (1980) Natural cytotoxicity in humans: susceptibility of freshly isolated tumor cells to lysis. J Natl Cancer Inst 65:257

    Google Scholar 

  47. Yogeeswaran G, Welsh RM, Gronberg A, Kiessling R, Patarroyo M, Klein G., Gidlund M, Wigzell H, Nilsson K (1982) Surface sialic acid of tumor cells inversely correlates with susceptibility to natural killer cell mediated lysis. In: Herberman RB (ed) NK cells and other natural effector cells. Academic, London

    Google Scholar 

  48. Yong WW, Durdik JM, Urdal D, Hakomori SI, Henney CS (1981) Glycolipid expression in lymphoma cell variants: chemical quantity, immunologic reactivity and correlations with susceptibility to NK cells. J Immunol 126:1

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental Pathology, Pathologisch Institut, Pasteurstraat 2, 3511 HX, Utrecht, The Netherlands

    Willem Den Otter

Authors
  1. Willem Den Otter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Den Otter, W. Tumor cells do not arise frequently. Cancer Immunol Immunother 19, 159–162 (1985). https://doi.org/10.1007/BF00199220

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199220

Keywords

Search

Navigation